Venetoclax Combined With Azactidine in the Treatment of ALAL | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Venetoclax Combined With Azactidine in the Treatment of ALAL	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute biphenotypic leukemia, acute leukemia of ambiguous lineage, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm	Recruiting	Phase 2	2025-12-16		NCT05901974

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Affiliated Hospital of Nantong University	71
Canglang Hospital of Suzhou	2
First Affiliated Hospital of Pingdingshan University	2
Jining Medical University	15
Northern Jiangsu People's Hospital	51
Second Affiliated Hospital of Wannan Medical College	3
Sheng-Li Xue, MD	2
Suzhou Hospital of Traditional Chinese Medicine	9
The First Affiliated Hospital of Bengbu Medical University	47
The Second People's Hospital of Huai'an	14

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The First Affliated Hospital of Soochow University	Suzhou	China	2